Biotech & Pharma
Health & Science
Exclusive analysis of biotech, pharma, and the life sciences
By Mario Aguilar and Jan. 6, 2022
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and Thursday.
Chatbots help telehealth companies rethink the front desk
Most telehealth companies haven’t cracked the code to profitability yet. But a growing number are hoping automation — whether it’s text-based chatbots, questionnaires, or followups — could help them trim costs and treat more patients with fewer resources. And as Amwell CEO Roy Schoenberg points out, automation could help telehealth companies tap into a potentially more lucrative chronic care market by helping them check on patients more frequently. Still, experts warn there are risks to an overreliance on automation, including the sidelining of patients who don’t speak English or who can’t navigate the tech. “Patients who are more on the margins, who have more difficulty accessing the system, are going to have even more trouble accessing the system,” Peter Yellowlees, a psychiatrist at UC Davis Health, told Mohana. She has the full story.
What’s interesting from CES 2022 (so far…)
The annual Consumer Electronics Show is off to a somewhat muted start after many companies and attendees pulled out at the last minute following fears about the Omicron variant, but there have still been some announcements of interest so far.
Takeaways from the Holmes verdict
After Theranos founder Elizabeth Holmes was found guilty on several charges of fraud this week, Casey talked to experts about takeaways from the trial. Maybe the most striking aspect of the convictions, they said, is that investors ultimately proved more compelling victims than the patients who received flawed test results from Theranos. Holmes gave investors information she knew was false or misleading, and those investors relied on those falsehoods when they agreed to give large sums of money to Theranos. The line between Holmes and patients is more circuitous, making it harder to establish that her actions directly impacted their thinking and decisions when they used Theranos’ faulty technology. Read more.
California mandate gives at-home test makers a boost
California is the first state mandating that health insurers — including its Medicaid program — pay for at-home tests detecting sexually transmitted diseases as rates climb across the country, Kaiser Health News’ Rachel Bluth reports. If other states follow suit, it could mean bigger business for venture-backed test kit companies like Everly Health and LetsGetChecked, which have processed tens of millions of Covid-19 tests over the past two years.
Hospitals leave mobile opportunities on the table
Smartphones and tablets have garnered some hype as solutions to pernicious health care bottlenecks, like difficulties pulling up current EHRs when caring for patients. But health care workers aren’t sold on on mobile tech yet. A new small study aiming to understand where the devices can improve hospital workflow concluded that what hospitalists want most is tech to help them communicate with their teams. The study, published in JMIR Human Factors, canvassed just 12 doctors, nurses, and residents. Their overarching opinion: mobile devices and task-specific apps could alleviate burden on hospitalists having to jog their memories to answer patient questions and could also reduce redundant actions in the hospital.
Seeds and acquisitions
What we’re reading
Health Tech Correspondent
Mario covers how technology is transforming health care.
This name will appear with your comment
There was an error saving your display name. Please check and try again.
By , Katie Palmer and Mario Aguilar
By Adam Feuerstein
By Kate Sheridan
Reporting from the frontiers of health and medicine